EN
Press Releases
-
February 21, 2023, Beijing, China – Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced its
-
![SINOVAC's Hepatitis A Vaccine Healive<sup>®</sup> Approved in Kyrgyzstan]()
February 8, 2023, Beijing, China – Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that its in
-
![SINOVAC Provides Vaccines to Step Up Preventative Healthcare for Children in Turkey]()
Company's Overseas Delivery of Varicella Vaccine and Approval to Expand Use of CoronaVac Will Help Turkish Minors Combat Infectious DiseasesFebruary 3, 2023, Beijing -- Sinovac Biotech Ltd. ("
-
![SINOVAC's Hepatitis A Vaccine Healive<sup>®</sup> Approved in Lebanon]()
January 12, 2023, Beijing, China – January 12, 2023, Beijing, China – Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical produ
-
![Study Proves the Immunogenicity and Safety of Co-administration with SINOVAC's WHO Prequalified Varicella and Hepatitis A Vaccines to 1 Year Old]()
January 6, 2023, Beijing -- Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that a recen
